CD19 and non-small cell lung carcinoma: We observed high frequencies of CD73 expression among CD19+ cells and CD8+ T cells in the peripheral blood of healthy donors which was significantly reduced in the peripheral blood of early NSCLC patients (online supplemental figure S2).